par Meeus, P.;Demuynck, H;Martiat, Philippe ;Michaux, Lucienne;Wouters, E;Hagemeijer, Anne
Référence Leukemia, 17, 2, page (465-467)
Publication Publié, 2003-02
Référence Leukemia, 17, 2, page (465-467)
Publication Publié, 2003-02
Article révisé par les pairs
Titre: |
|
Auteur: | Meeus, P.; Demuynck, H; Martiat, Philippe; Michaux, Lucienne; Wouters, E; Hagemeijer, Anne |
Informations sur la publication: | Leukemia, 17, 2, page (465-467) |
Statut de publication: | Publié, 2003-02 |
Sujet CREF: | Sciences bio-médicales et agricoles |
MeSH keywords: | Adult |
Antineoplastic Agents -- adverse effects | |
Antineoplastic Agents -- therapeutic use | |
Chromosome Aberrations | |
Female | |
Humans | |
In Situ Hybridization, Fluorescence | |
Karyotyping | |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- drug therapy | |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- genetics | |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive -- pathology | |
Male | |
Middle Aged | |
Philadelphia Chromosome | |
Piperazines -- adverse effects | |
Piperazines -- therapeutic use | |
Pyrimidines -- adverse effects | |
Pyrimidines -- therapeutic use | |
Time Factors | |
Note générale: | Case Reports |
Letter | |
SCOPUS: le.j | |
Langue: | Anglais |
Identificateurs: | urn:issn:0887-6924 |
info:doi/10.1038/sj.leu.2402791 | |
info:pii/2402791 | |
info:scp/0344626927 | |
info:pmid/12592350 |